NO955258D0 - Medisinsk anvendelse av enzymer - Google Patents

Medisinsk anvendelse av enzymer

Info

Publication number
NO955258D0
NO955258D0 NO955258A NO955258A NO955258D0 NO 955258 D0 NO955258 D0 NO 955258D0 NO 955258 A NO955258 A NO 955258A NO 955258 A NO955258 A NO 955258A NO 955258 D0 NO955258 D0 NO 955258D0
Authority
NO
Norway
Prior art keywords
enzymes
medical use
medical
Prior art date
Application number
NO955258A
Other languages
English (en)
Other versions
NO955258L (no
Inventor
Tracey Lehanne Mynott
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO955258D0 publication Critical patent/NO955258D0/no
Publication of NO955258L publication Critical patent/NO955258L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO955258A 1993-06-25 1995-12-22 Medisinsk anvendelse av enzymer NO955258L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313188A GB9313188D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes
PCT/GB1994/001368 WO1995000169A1 (en) 1993-06-25 1994-06-24 Medical use of stem bromelain protease

Publications (2)

Publication Number Publication Date
NO955258D0 true NO955258D0 (no) 1995-12-22
NO955258L NO955258L (no) 1996-02-22

Family

ID=10737823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955258A NO955258L (no) 1993-06-25 1995-12-22 Medisinsk anvendelse av enzymer

Country Status (11)

Country Link
US (1) US5824305A (no)
EP (1) EP0713396A1 (no)
JP (1) JPH08511687A (no)
AU (1) AU681891B2 (no)
CA (1) CA2165787A1 (no)
FI (1) FI956178A (no)
GB (1) GB9313188D0 (no)
NO (1) NO955258L (no)
NZ (1) NZ267660A (no)
SG (1) SG42309A1 (no)
WO (1) WO1995000169A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
AU6303898A (en) 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
DK1096951T3 (da) 1998-07-15 2002-10-21 Ursapharm Arzneimittel Gmbh Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
WO2007047205A2 (en) * 2005-10-11 2007-04-26 Amano Enzyme Usa Co., Ltd. Enzyme inhibitors of pai-1
EP2036978A1 (en) * 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
US11382958B2 (en) 2016-01-31 2022-07-12 Mediwound Ltd. Debriding composition for treating wounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197291A (en) * 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
GB8821049D0 (en) * 1988-09-08 1988-10-05 Health Lab Service Board Method & composition for treatment & prevention of viral infections
SG42865A1 (en) * 1991-07-24 1997-10-17 Enzacor Pty Ltd Therapeutic compositions and methods
JPH08503691A (ja) * 1992-06-30 1996-04-23 コーテックス リミテッド 下痢の治療における酵素、特にブロメラインの使用

Also Published As

Publication number Publication date
FI956178A (fi) 1996-02-21
WO1995000169A1 (en) 1995-01-05
JPH08511687A (ja) 1996-12-10
NZ267660A (en) 1997-05-26
SG42309A1 (en) 1997-08-15
AU681891B2 (en) 1997-09-11
AU7002794A (en) 1995-01-17
EP0713396A1 (en) 1996-05-29
NO955258L (no) 1996-02-22
GB9313188D0 (en) 1993-08-11
US5824305A (en) 1998-10-20
FI956178A0 (fi) 1995-12-21
CA2165787A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
NO180145C (no) Tannbörste og tildannelse av samme
DE69425846D1 (de) Fieberthermometer
FI965204A (fi) Bromelaiinin lääkekäyttö
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
DK73891D0 (da) Enzymbehandling
NO955258D0 (no) Medisinsk anvendelse av enzymer
NO940190D0 (no) Anvendelse av x-ketoglutarat
FI954422A0 (fi) Ferroseenin käyttö
NO963482D0 (no) Medisinsk anvendelse av bromelain
GB9526691D0 (en) Medical use of proteases
NO931399D0 (no) Anvendelse av naturstein
NO944839D0 (no) Anvendelse av vismut
GB9308164D0 (en) Medical use of enzymes
GB9313189D0 (en) Medical use of enzymes
KR950013311U (ko) 식기세척기의 표시장치
SE9302529D0 (sv) Maximal anvaendning av solfaangare
ZA934714B (en) Medical use of enzymes
KR940027060U (ko) 임페라 유니트의 회전체
FI1218U1 (fi) Anordning foer foeljandet av en patients vitalfunktioner
KR940018967U (ko) 식기세척기의 살수장치
KR950013629U (ko) 제함기의 제함장치
SE9603101D0 (sv) Medicinsk användning av enzym
FI930700A0 (fi) Anordningar foer avlaegsnande av goedsel
SE9301995D0 (sv) Ny medicinsk anvaendning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application